Opinion

Video

Adherence and Time Spent Receiving IV Iron Infusions

Author(s):

Melody Chang, RPh, MBA, BCOP,Andre D. Harvin, PharmD, MS, MBA

Panelists discuss how IV iron formulations requiring fewer infusion visits tend to have better adherence rates, while the ongoing nursing shortage has created additional challenges in scheduling and administering IV iron treatments, leading clinicians to favor products that can achieve iron repletion in fewer sessions.

Video content above is prompted by the following:

  • Adherence to recommended treatment dosing tends to decline as the number of separate recommended infusion visits increases. Could you share your clinical experience on how variations in dosing among different agents influence patient adherence?
  • Has the recent nursing shortage impacted your practice in patients requiring IV iron formulations?
Related Videos
4 experts are featured in this series.
5 experts are featured in this series
3 experts are featured in this series.
4 experts are featured in this series.
3 experts are featured in this series.
1 expert is featured in this series.
5 experts are featured in this series
Nihar Desai, MD, MPH
Related Content
Patients with PAH had distinct PA flow characteristics compared with those with PH-HFpEF. | Image credit: Thirawat - stock.adobe.com
March 21st 2025

Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics

Jared Kaltwasser
Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Person using social media | Image Credit: escapejaja - stock.adobe.com
March 19th 2025

Social Media Insights Shed Light on Patient Experiences With Uncomplicated UTIs

Brooke McCormick
To better understand patient experiences, the researchers analyzed qualitative and quantitative data from their social media posts about uncomplicated urinary tract infections (UTIs).
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
gene therapy | Image Credit: © Treecha - stock.adobe.com
March 19th 2025

EMBARK Data Show Continued Improvements With DMD Gene Therapy

Christina Mattina
Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Gene therapy | Image Credit: © RFBSIP - stock.adobe.com
March 18th 2025

Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic

Christina Mattina
The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo